Alzheimer's vaccine triggers brain inflammation when brain amyloid burden is high
Monday, November 14, 2011 - 15:30
in Health & Medicine
Patients with Alzheimer's disease who are in the early stages of their illness will likely benefit most from vaccine therapies now being tested in a number of human clinical trials, say researchers from Georgetown University Medical Center (GUMC).